The therapeutic potential of monoamine oxidase inhibitors
Identifieur interne : 001178 ( Main/Exploration ); précédent : 001177; suivant : 001179The therapeutic potential of monoamine oxidase inhibitors
Auteurs : Moussa B. H. Youdim [Israël] ; Dale Edmondson [États-Unis] ; Keith F. Tipton [Irlande (pays)]Source :
- Nature Reviews Neuroscience [ 1471-003X ] ; 2006-04.
Abstract
Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such. It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity. However, many claims and some counter-claims have been made about the physiological importance of these enzymes and the potential of their inhibitors. We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.
Url:
DOI: 10.1038/nrn1883
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The therapeutic potential of monoamine oxidase inhibitors</title><author><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name></author><author><name sortKey="Edmondson, Dale" sort="Edmondson, Dale" uniqKey="Edmondson D" first="Dale" last="Edmondson">Dale Edmondson</name></author><author><name sortKey="Tipton, Keith F" sort="Tipton, Keith F" uniqKey="Tipton K" first="Keith F." last="Tipton">Keith F. Tipton</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D7CC3B3075538DC26D4CEA4B55124E36713D9B3F</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1038/nrn1883</idno><idno type="url">https://api.istex.fr/document/D7CC3B3075538DC26D4CEA4B55124E36713D9B3F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000B94</idno><idno type="wicri:Area/Main/Curation">000A47</idno><idno type="wicri:Area/Main/Exploration">001178</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The therapeutic potential of monoamine oxidase inhibitors</title><author><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Technion-Rappaport Family Faculty of Medicine, Eve Topf and US National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases, P.O. Box 9697, 31096 Haifa</wicri:regionArea><wicri:noRegion>31096 Haifa</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Pharmacology, P.O. Box 9697, 31096 Haifa</wicri:regionArea><wicri:noRegion>31096 Haifa</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Israël</country></affiliation></author><author><name sortKey="Edmondson, Dale" sort="Edmondson, Dale" uniqKey="Edmondson D" first="Dale" last="Edmondson">Dale Edmondson</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Emory University School of Medicine, Department of Biochemistry, 1510 Clifton Road, Atlanta, Georgia 30322</wicri:regionArea><wicri:noRegion>Georgia 30322</wicri:noRegion></affiliation></author><author><name sortKey="Tipton, Keith F" sort="Tipton, Keith F" uniqKey="Tipton K" first="Keith F." last="Tipton">Keith F. Tipton</name><affiliation wicri:level="1"><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Trinity College Dublin, Department of Biochemistry, Dublin 2</wicri:regionArea><wicri:noRegion>Dublin 2</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Nature Reviews Neuroscience</title><idno type="ISSN">1471-003X</idno><idno type="eISSN">1471-0048</idno><imprint><publisher>Nature Publishing Group</publisher><date type="published" when="2006-04">2006-04</date><biblScope unit="volume">7</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="295">295</biblScope><biblScope unit="page" to="309">309</biblScope></imprint><idno type="ISSN">1471-003X</idno></series><idno type="istex">D7CC3B3075538DC26D4CEA4B55124E36713D9B3F</idno><idno type="DOI">10.1038/nrn1883</idno><idno type="ArticleID">nrn1883</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1471-003X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such. It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity. However, many claims and some counter-claims have been made about the physiological importance of these enzymes and the potential of their inhibitors. We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.</div></front></TEI><affiliations><list><country><li>Irlande (pays)</li><li>Israël</li><li>États-Unis</li></country></list><tree><country name="Israël"><noRegion><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name></noRegion><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name></country><country name="États-Unis"><noRegion><name sortKey="Edmondson, Dale" sort="Edmondson, Dale" uniqKey="Edmondson D" first="Dale" last="Edmondson">Dale Edmondson</name></noRegion></country><country name="Irlande (pays)"><noRegion><name sortKey="Tipton, Keith F" sort="Tipton, Keith F" uniqKey="Tipton K" first="Keith F." last="Tipton">Keith F. Tipton</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001178 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001178 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D7CC3B3075538DC26D4CEA4B55124E36713D9B3F
|texte= The therapeutic potential of monoamine oxidase inhibitors
}}
| This area was generated with Dilib version V0.6.23. |  |